Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 15,935,241
- Total 13F value
- $79,992,923
- Share change
- -304,346
- SEC-reported price per share
- $5.02
- Number of holders
- 29
- Value change
- -$1,598,866
- Number of buys
- 11
- Number of sells
- 11
- Shares outstanding
- 53,364,241
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
29
Top holders
10
SCPH full security history
Ownership snapshot
Full 13F holder table
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F
Highest disclosed value: $31,901,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC has the largest disclosed position value at $31.9M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
ORBIMED ADVISORS LLC
$31.9M
5AM Venture Management, LLC
$25.48M
RA CAPITAL MANAGEMENT, L.P.
$18.16M
AIGH Capital Management LLC
$8.21M
Ikarian Capital, LLC
$5.99M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$31,901,000
4,797,148 shares
|
— | 30 Sep 2021 |
| 5AM Venture Management, LLC |
13F
Company
|
—
denominator unverified
|
$25,479,000
3,831,474 shares
|
— | 30 Sep 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
—
denominator unverified
|
$18,162,000
2,731,170 shares
|
— | 30 Sep 2021 |
| AIGH Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$8,207,000
1,234,121 shares
|
— | 30 Sep 2021 |
| Ikarian Capital, LLC |
13F
Company
|
—
denominator unverified
|
$5,994,000
901,362 shares
|
— | 30 Sep 2021 |
| J. Goldman & Co LP |
13F
Company
|
—
denominator unverified
|
$5,270,000
792,421 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
15,935,241
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
29
Q4 2021 holders
29
Holder diff
0
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|